ClassID:

95888 āŽ˜

C07F9/222 - CPC Classification

Classification description:

Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds without P—C bonds; Amides of acids of phosphorus Amides of phosphoric acids

Recent Application in this class:
#1
20260008796
2026-01-08

INDANONE DERIVATIVES AS NUCLEOBASE BUILDINGS BLOCK FOR ON-DNA ALDEHYDE CAPTURE

#2
20240398962
2024-12-05

DENDRIMER-GLUTAMINE ANTAGONIST CONJUGATES AND METHODS OF USE THEREOF

#3
20240025930
2024-01-25

SMALL MOLECULE INHIBITORS SELECTIVE FOR POLO-LIKE KINASE PROTEIN

#4
20240016799
2024-01-18

ANTI-INFLAMMATORY, ANTI-CANCER, AND ANTI-ANGIOGENIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF MAKING AND USING THEREOF

#5
20240002374
2024-01-04

5-MEMBERED HETEROARYLAMINOSULFONAMIDES FOR TREATING CONDITIONS MEDIATED BY DEFICIENT CFTR ACTIVITY

#6
20230227480
2023-07-20

POLYHYDROXYLATED CYCLOPENTANE DERIVATIVES AND METHODS OF USE

#7
20220204541
2022-06-30

Prodrugs of a CDK inhibitor for treating cancers

#8
20220162153
2022-05-26

Process for making levoamphetamine

#9
20220119430
2022-04-21

Ifosfamide intermediate, preparation method and application thereof

#10
20210139897
2021-05-13

OLIGONUCLEOTIDE ANALOGUES HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS

#11
20210009625
2021-01-14

Diastereoselective synthesis of phosphate derivatives

#12
20200399297
2020-12-24

Small molecule inhibitors selective for polo-like kinase proteins

#13
20200339615
2020-10-29

Prodrugs of a CDK inhibitor for treating cancers

#14
20200323888
2020-10-15

INHIBITORS

#15
20200246330
2020-08-06

Anti-inflammatory, anti-cancer, and anti-angiogenic compounds, pharmaceutical compositions, and methods of making and using thereof

#16
20200190125
2020-06-18

Phosphoramidate compound and preparation method and crystal thereof

#17
20200131212
2020-04-30

Compound for treating metabolic diseases and preparation method and use thereof

#18
20190382758
2019-12-19

Artificial single guide RNA and use thereof

#19
20190350948
2019-11-21

Stable liquid formulations of cyclophosphamide and its impurities

#20
20190332010
2019-10-31

Energy-sensitive composition, cured product, and pattern forming method

#21
20190218551
2019-07-18

Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

#22
20190218365
2019-07-18

Non-halogenated flame retardant hindered amine light stabilizer cross-linkers

#23
20190085149
2019-03-21

Non-halogenated flame retardant hindered amine light stabilizer cross-linkers

#24
20190071557
2019-03-07

Flame-retardant microcapsule containing cyclic phosphazene

#25
20190062331
2019-02-28

6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-5-one allosteric modulators of the M4 muscarinic acetylcholine receptor

#26
20180362571
2018-12-20

Diastereoselective synthesis of phosphate derivatives

#27
20180297903
2018-10-18

Urea-based blend composition and method for the manufacture thereof

#28
20180273557
2018-09-27

Process for recovering a mixture comprising a (thio)phosphoric acid derivative

#29
20180244701
2018-08-30

Phosphoramidate compound and preparation method and crystal thereof

#30
20170283445
2017-10-05

Small Molecule Inhibitors Selective For Polo-Like Kinase Proteins

#31
20170198287
2017-07-13

Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

#32
20170183342
2017-06-29

6,7-dihydro-5H-pyrrolo[3,4-B]pyridin-5-one allosteric modulators of the M4 muscarinic acetylcholine receptor

#33
20160376589
2016-12-29

Micro-RNA inhibitor

#34
20160289253
2016-10-06

Creatine phosphate analog prodrugs, compositions and methods of use thereof

#35
20160215005
2016-07-28

SYNTHESIS AND FORMULATIONS OF SALTS OF ISOPHOSPHORAMIDE MUSTARD AND ANALOGS THEREOF

#36
20160015727
2016-01-21

Pantothenate derivatives for the treatment of neurologic disorders

#37
20150328238
2015-11-19

Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof

#38
20150183810
2015-07-02

Synthesis of racemic amphetamine derivatives by cuprate addition reaction with aziridine phosphoramidate compounds

#39
20150152125
2015-06-04

Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents

#40
20150073140
2015-03-12

Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

#41
20150073124
2015-03-12

Micro-RMA inhibitor

#42
20150018579
2015-01-15

SYNTHESIS OF HIGH PURITY DMT-C3-DISULFIDE PHOSPHORAMIDITE

#43
20140378704
2014-12-25

Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof

#44
20140309191
2014-10-16

Salts, prodrugs and polymorphs of fab I inhibitors

#45
20140135294
2014-05-15

Pantothenate derivatives for the treatment of neurologic disorders

#46
20130211065
2013-08-15

Purification of synthetic oligonucleotides

#47
20130203705
2013-08-08

Pyrazole compounds acting against allergic, immune and inflammatory conditions

#48
20130172293
2013-07-04

DRUG AGAINST CENTRAL NERVOUS SYSTEM INFLAMMATION

#49
20130149296
2013-06-13

Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents

#50
20120065169
2012-03-15

Oligonucleotide analogues having modified intersubunit linkages and/or terminal groups

#51
20110251158
2011-10-13

FULLERENE THERAPIES FOR INFLAMMATION AND INHIBITION OF BUILD-UP OF ARTERIAL PLAQUE

#52
20110212921
2011-09-01

Synthesis and formulations of salts of isophosphoramide mustard and analogs thereof

#53
20110143971
2011-06-16

Volatile-phosphorus free gelling agents

#54
20110028761
2011-02-03

Process for the preparation of triamides from ammonia and amido-dichlorides

#55
20100215611
2010-08-26

USE OF PHOSPHORIC TRIAMIDES IN TOILETS

#56
20100183517
2010-07-22

Peptidomimetic inhibitors of PSMA, compounds comprising them, and methods of use

#57
20090324704
2009-12-31

PHOSPHATE DIESTER AMIDES

#58
20090048372
2009-02-19

Protective barrier composition comprising reaction of phosphorous acid with amines applied to a substrate

#59
20090042927
2009-02-12

Salts, prodrugs and polymorphs of fab I inhibitors

#60
20080267945
2008-10-30

Salts of isophosphoramide mustard and analogs thereof as anti-tumor Agents

#61
20070219165
2007-09-20

Peptidomimetic inhibitors of PSMA, compounds comprising them, and methods of use

#62
20060089333
2006-04-27

Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents

#63
20050261252
2005-11-24

LPA receptor agonists and antagonists and methods of use

#64
16745689
2022-02-22

Capsaicinoid prodrug compounds and their use in treating medical conditions